Marvelon

Desogestrel/Ethinylestradiol, the active ingredients in Marvelon, are a combined oral contraceptive presented as 150 µg desogestrel / 30 µg ethinylestradiol tablets for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age.

GNH USA supplies Marvelon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marvelon, a combined oral contraceptive, is indicated for hormonal regulation of the reproductive system.

Pregnancy prevention: provides reliable contraceptive protection for women of childbearing potential. Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduce menstrual discomfort. Management of estrogen‑dependent conditions: can be used under medical supervision to treat mild acne or premenstrual symptoms.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional tension‑type headaches. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Arterial thrombosis: stroke or heart attack risk. - Severe hypertension: markedly elevated blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Anaphylaxis: severe allergic reaction. - Visual disturbances: sudden vision changes or loss.

Before starting Marvelon, consider the following precautions.

Assess cardiovascular risk: evaluate history of clotting disorders, smoking, or hypertension. Avoid in estrogen‑dependent tumors: contraindicated in known breast or endometrial cancer. Consider liver function: not recommended for severe hepatic disease. Monitor blood pressure: regular checks are advised during therapy. Inform about smoking: especially >15 cigarettes/day in women over 35. Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Marvelon may interact with other medicines; review the following.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin, phenobarbital): reduce contraceptive efficacy. - Rifampin or other strong CYP3A4 inducers: may cause contraceptive failure. - Certain antiretroviral protease inhibitors: can alter hormone levels.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: may slightly diminish effectiveness. - SSRIs (selective serotonin reuptake inhibitors): may increase risk of mood changes. - Herbal supplements like ginkgo biloba: could increase bleeding tendency.